Applicant, as named in the Orange Book

Salix Pharms

Next listed expiry: Xifaxan on 24 Jul 2029. 2 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Xifaxan · 2 strengths rifaximin	rifaximin	021361	24 Jul 2029	patent, carve-out possible
Relistor · 3 strengths methylnaltrexone bromide	methylnaltrexone bromide	021964	31 Dec 2030	patent, carve-out possible

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Moviprep ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate	ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate	021881	open now	no listed protection